479 related articles for article (PubMed ID: 23838047)
1. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
[TBL] [Abstract][Full Text] [Related]
2. Vaccines to Emerging Viruses: Nipah and Hendra.
Amaya M; Broder CC
Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
[TBL] [Abstract][Full Text] [Related]
3. Hendra virus and Nipah virus animal vaccines.
Broder CC; Weir DL; Reid PA
Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
[TBL] [Abstract][Full Text] [Related]
4. Developments towards effective treatments for Nipah and Hendra virus infection.
Bossart KN; Broder CC
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
[TBL] [Abstract][Full Text] [Related]
5. Hendra and Nipah infection: emerging paramyxoviruses.
Aljofan M
Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
[TBL] [Abstract][Full Text] [Related]
6. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
[TBL] [Abstract][Full Text] [Related]
7. Immunization strategies against henipaviruses.
Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
[TBL] [Abstract][Full Text] [Related]
8. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization and active vaccination against Hendra and Nipah viruses.
Broder CC
Dev Biol (Basel); 2013; 135():125-38. PubMed ID: 23689890
[TBL] [Abstract][Full Text] [Related]
10. Hendra and Nipah viruses: different and dangerous.
Eaton BT; Broder CC; Middleton D; Wang LF
Nat Rev Microbiol; 2006 Jan; 4(1):23-35. PubMed ID: 16357858
[TBL] [Abstract][Full Text] [Related]
11. Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials.
Rodrigue V; Gravagna K; Yao J; Nafade V; Basta NE
Trop Med Int Health; 2024 May; 29(5):354-364. PubMed ID: 38415314
[TBL] [Abstract][Full Text] [Related]
12. Hendra and Nipah viruses: pathogenesis and therapeutics.
Eaton BT; Broder CC; Wang LF
Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
[TBL] [Abstract][Full Text] [Related]
13. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.
Defang GN; Khetawat D; Broder CC; Quinnan GV
Vaccine; 2010 Dec; 29(2):212-20. PubMed ID: 21050901
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
Lo MK; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Scholte FEM; Shrivastava-Ranjan P; Montgomery JM; Nichol ST; Weissman D; Spiropoulou CF
J Infect Dis; 2020 May; 221(Suppl 4):S493-S498. PubMed ID: 31751453
[TBL] [Abstract][Full Text] [Related]
15. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
16. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.
Pallister J; Middleton D; Wang LF; Klein R; Haining J; Robinson R; Yamada M; White J; Payne J; Feng YR; Chan YP; Broder CC
Vaccine; 2011 Aug; 29(34):5623-30. PubMed ID: 21689706
[TBL] [Abstract][Full Text] [Related]
17. Virology. A henipavirus vaccine in sight.
von Messling V; Cattaneo R
Science; 2012 Aug; 337(6095):651-2. PubMed ID: 22879489
[No Abstract] [Full Text] [Related]
18. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
[TBL] [Abstract][Full Text] [Related]
19. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.
Mire CE; Geisbert JB; Agans KN; Feng YR; Fenton KA; Bossart KN; Yan L; Chan YP; Broder CC; Geisbert TW
J Virol; 2014 May; 88(9):4624-31. PubMed ID: 24522928
[TBL] [Abstract][Full Text] [Related]
20. The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus?
Breed AC; Meers J; Sendow I; Bossart KN; Barr JA; Smith I; Wacharapluesadee S; Wang L; Field HE
PLoS One; 2013; 8(4):e61316. PubMed ID: 23637812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
